Navigation Links
ARIUS to present at Chinese Global Financial Forum
Date:10/19/2007

TORONTO, Oct. 19 /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX: ARI), a biotechnology company discovering and developing the next wave of antibody therapeutics, today announced that David Young, MD, President and Chief Executive Officer of ARIUS, will speak at the Chinese Global Financial Forum. Dr. Young will present on Saturday October 20th at 3:25 p.m. and will be available prior to and following his presentation at booth #706. The conference is being held at the Hilton Suites Toronto/Markham Conference Centre & Spa. Dr. Young will provide an overview of ARIUS' business and will update the audience on milestones for the Company's lad programs in cancer.

About ARIUS

ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics. Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRST(TM), that rapidly identifies and selects antibodies based on their functional ability to affect disease. This antibody generation engine has enabled ARIUS to assemble a portfolio of more than 400 antibody candidates. In addition to the antibodies it is developing in-house, ARIUS has ongoing partnerships with key biotechnology and drug development companies. ARIUS is listed on the TSX under the symbol "ARI". For further information, visit http://www.ariusresearch.com

Forward-Looking Statements

Certain statements in this news release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause our actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Forward-looking statements in this release include, but are not limited to, ARIUS successfully advancing its new product programs as well as licensing opportunities
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Streptococcus salivarius
2. Streptococcus salivarius
3. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
4. Wisconsin firms to present at Cleantech venture capital event
5. New Sonic Foundry search engine finds words, phrases in video presentations
6. Lone Wisconsin firm to present at InvestMidwest
7. Sonic Foundry creates search engine for 7,000 expert video presentations
8. InvestMidWest calls for business presentations
9. Wicab to present BrainPort at Boston conference
10. Three more Wisconsin firms to present at venture forum
11. Six Wisconsin firms to present at BIO Mid-America VentureForum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... The report, "Synthetic Biology Market by ... Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & ... Global Forecast to 2018", analyses and studies ... challenges. , Browse 99 market data tables ... and in-depth TOC of the global synthetic ...
(Date:11/21/2014)... Dallas, Texas (PRWEB) November 21, 2014 ... Industry” is a professional and in-depth research report ... information, including its definition, classification, application, and industry ... research covers the international market analysis, including China’s ... covering macroeconomic environment & economic situation analysis. The ...
(Date:11/18/2014)... Cord Blood Registry® (CBR®) announces that ... World Stem Cell Summit, the largest global meeting of stem ... Cell Summit will be held December 3-5 at the Marriott ... The World Stem Cell Summit aims ... therapies, convening the most prominent figures in the field to ...
(Date:11/18/2014)... NJ (PRWEB) November 18, 2014 ... Quality and Transparency Reporting solutions, announced today that ... live using its Consummate Provider™ solution in both ... is a Global, SaaS based, Data Quality remediation ... and their third party Providers improve their ability ...
Breaking Biology Technology:Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 2Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 3Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 4International Transformer Industry - Analysis on Applications, Development & Forecasts Now Available at ReportsnReports.com 2International Transformer Industry - Analysis on Applications, Development & Forecasts Now Available at ReportsnReports.com 3Cord Blood Registry Sponsors 2014 World Stem Cell Summit 2Cord Blood Registry Sponsors 2014 World Stem Cell Summit 3Alanda Software Completes Successful Implementation of Global Data Quality & Vendor Management Solution for Top Tier Global Biopharmaceutical Company 2
... traditional August break, the Senate may help decide the future ... hope a scientifically sound and ethical resolution is reached - ... ,Just as Republicans in the Wisconsin Legislature are divided over ... President Bush suffered a rare political defeat in May when ...
... technology provider Sonic Foundry announced on Monday ... region, would be promoted to senior vice president of ... marketing of the company's Mediasite applications. , ,Prior to ... Corp.'s Americas Enterprise Business division and executive vice ...
... investment wholly on the basis of anticipated savings in ... are merely deluding themselves. In fact, if a company ... that gross inefficiencies exist in its operations, and that ... RFID. , ,The benefits of RFID related to lower ...
Cached Biology Technology:Stem cell debate in Washington grows hotter as summer recess nears 2Stem cell debate in Washington grows hotter as summer recess nears 3The key to finding RFID's ROI 2The key to finding RFID's ROI 3The key to finding RFID's ROI 4
(Date:11/12/2014)... Fla. , Nov. 12, 2014 Crossmatch™, ... today that its U.are.U ® fingerprint readers have ... chain in Central Mexico . The ... 2014 to eliminate payroll issues caused by employees clocking ... installing the U.are.U fingerprint readers, Montparnasse relied on paper ...
(Date:11/7/2014)... professor, biomedical engineering, in the Grove School of ... have identified a molecule that could lead to ... forms of breast cancer. , Triple negative breast ... to aggressive proliferation and metastasis and a lack ... discovered the overexpression of intercellular adhesion molecule-1 (ICAM-1) ...
(Date:11/6/2014)... Fla. -- A groundbreaking paper from a team of ... understanding of how plants could adapt to and survive ... research, published in the latest issue of the journal ... chromatin (the complex of DNA and proteins) is organized ... so that some genes are turned on and others ...
Breaking Biology News(10 mins):Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2Maize analysis yields whole new world of genetic science 2
... human embryonic stem cell research receives a tremendous amount ... potential of adult stem cells for possible therapies. But ... research isn't fraught with the controversies that surround embryonic ... isolate and then to multiply in a lab dish. ...
... of Washington and their colleagues at other research centers have ... while reducing the impact of the aging process. Their study, ... May 5, lends more credence to the free-radical theory of ... "free radicals," can be damaging to the body at the ...
... that they developed, University at Buffalo scientists have for ... living mice with an efficiency that is similar to, ... toxic effect, according to a paper published this week ... The paper describes how the UB scientists used gene-nanoparticle ...
Cached Biology News:Researchers discover mechanism for multiplying adult stem cells 2Researchers extend mouse lifespan by protecting against free radicals 2Researchers extend mouse lifespan by protecting against free radicals 3Using nanoparticles, in vivo gene therapy activates brain stem cells 2Using nanoparticles, in vivo gene therapy activates brain stem cells 3